Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Frontiers in Oncology
|
March 7, 2022
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial
Annika Kurreck, Volker Heinemann, Ludwig Fischer von Weikersthal, et al.
International Journal of Cancer
|
March 8, 2023
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM
Thorsten O Goetze, Ralf-Dieter Hofheinz, Timo Gaiser, et al.
Current Oncology (Toronto, Ont.)
|
June 27, 2023
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh<sup>®TM</sup>) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer
Klara Dorman, Stefan Boeck, Robert J Snijder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2023
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
Sylvie Lorenzen, Thorsten Oliver Götze, Peter Thuss-Patience, et al.
Lancet (London, England)
|
April 16, 2019
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Haematologica
|
December 6, 2018
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Christian Michel, Andreas Burchert, Andreas Hochhaus, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Frontiers in Oncology
|
March 7, 2022
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial
Annika Kurreck, Volker Heinemann, Ludwig Fischer von Weikersthal, et al.
International Journal of Cancer
|
March 8, 2023
Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM
Thorsten O Goetze, Ralf-Dieter Hofheinz, Timo Gaiser, et al.
Current Oncology (Toronto, Ont.)
|
June 27, 2023
Integrated Analysis of the RASH Study with the Use of the "Burden of Therapy" (BOTh<sup>®TM</sup>) Methodology-A Novel Tool for Assessing Adverse Events in Metastatic Pancreatic Cancer
Klara Dorman, Stefan Boeck, Robert J Snijder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2023
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
Sylvie Lorenzen, Thorsten Oliver Götze, Peter Thuss-Patience, et al.
Lancet (London, England)
|
April 16, 2019
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah-Eddin Al-Batran, Nils Homann, Claudia Pauligk, et al.
Haematologica
|
December 6, 2018
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Christian Michel, Andreas Burchert, Andreas Hochhaus, et al.
Page
of 6